🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 1b/2 trial studies the safety and best dose of lenalidomide when...
Status
Recruiting
Location
Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2019-11-28
Trial ID
NCT04110301
Treatments Being Tested
This study will evaluate the efficacy, safety, pharmacokinetics(PK), pharma...
Status
Active Not Recruiting
Location
Peking University People's Hospital
Start Date
2023-05-26
Trial ID
NCT05796206
Dose escalation and expansion phase I/IIa clinical study of recombinant hum...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-07-28
Trial ID
NCT04304040
Treatments Being Tested
This study will evaluate the efficacy and safety of MIL62 compared with pla...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-04-10
Trial ID
NCT07405970
This study is composed of two stages: Part A is a randomized, double-blind,...
Status
Active Not Recruiting
Location
Peking University People's Hospital
Start Date
2021-11-26
Trial ID
NCT07044115
Treatments Being Tested
This study was divided into two stages. In the first stage (Phase Ib), 30 s...
Status
Completed
Location
Peking University First Hospital
Start Date
2022-02-24
Trial ID
NCT05398653
Treatments Being Tested
This open-label, multicenter,dose-escalating phase I study was designed to ...
Status
Completed
Location
Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC)
Start Date
2017-02-10
Trial ID
NCT04103905
Treatments Being Tested